VHL and von Hippel-Lindau disease: Therefore, VHL’s canonical substrate, HIFα, cannot fully explain the complex genotype–phenotype manifestation within the VHL syndrome and there is no evidence that HIFα deregulation is sufficient to cause cancer11.